Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-22

Clinical Trial Update: Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating functional melatonin replacement to treat sleep disruptions in individuals with tetraplegia due to spinal cord injury; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Insomnia, Spinal Cord Injury | Phase 4 | Status: COMPLETED | Results posted: 2014-05-22